Human megakaryocytes and platelets contain the estrogen receptor β and androgen receptor (AR): Testosterone regulates AR expression

Blood

Volumn 95, Issue 7, 2000, Pages 2289-2296

  Khetawat, Gopal ^a   Faraday, Nauder ^a   Nealen, Michele L ^a   Vijayan, K Vinod ^a   Bolton, Everlie ^a   Noga, Stephen J ^a   Bray, Paul F ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR BETA; PROGESTERONE RECEPTOR; SEX HORMONE; TESTOSTERONE;

ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HORMONAL REGULATION; HUMAN; HUMAN CELL; MEGAKARYOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEX DIFFERENCE; THROMBOCYTE; THROMBOCYTE FUNCTION;

EID: 0034176820     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.7.2289     Document Type: Article

References (57)

1. National Heart, Lung, and Blood Institute. Morbidity and Mortality: 1996 Chartbook on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD: National Institutes of Health; 1996
2. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987;316:1105.
3. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med. 1991;325:1196.
4. Sullivan JM, Fowlkes LP. Estrogens, menopause, and coronary artery disease. Cardiol Clin. 1996; 14:105.
5. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280:605.
6. Daly E, Vessey MP, Hawkins MM, Carson JL, Gough P, Marsh S. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet. 1996;348:977.
7. Castellsague J, Perez Gutthann S, Garcia Rodriguez LA. Recent epidemiological studies of the association between hormone replacement therapy and venous thromboembolism: a review. Drug Saf. 1998;18:117.
8. Ruggeri ZM. Mechanisms initiating platelet thrombus formation. Thromb Haemost. 1997;78:611.
9. Faraday N, Goldschmidt-Clermont PJ, Bray PF. Gender differences in platelet GPIIb-IIIa activation. Thromb Haemost. 1997;77:748.
10. Jones SB, Bylund DB, Rieser CA, Shekim WO, Byer JA, Carr GW. α2-Adrenergic receptor binding in human platelets: alterations during the menstrual cycle. Clin Pharmacol Ther. 1983;34: 90
11. Tarantino MD, Kunicki TJ, Nugent DJ. The estrogen receptor is present in human megakaryocytes. Ann N Y Acad Sci 1994;714:293.
12. Chen LY, Mehta JL. Further evidence of the presence of constitutive and inducible nitric oxide synthase isoforms in human platelets. J Cardiovasc Pharmacol. 1996;27:154.
13. Marcus AJ, Silk ST, Safier LB, Ullman HL. Superoxide production and reducing activity in human platelets. J Clin Invest. 1977;59:149.
14. Broudy VC, Lin NL, Fox N, Taga T, Saito M, Kaushansky K. Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit. Blood. 1996;88:2026.
15. Ajayi AA, Mathur R, Halushka PV. Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses. Circulation. 1995;91:2742.
16. Johnson M, Ramey E, Ramwell PW. Sex and age differences in human platelet aggregation. Nature. 1975;253:355.
17. Wattel E, Gambier N, Caulier MT, Sautiere D, Bauters F, Fenaux P. Androgen therapy in myelodysplastic syndromes with thrombocytopenia: a report on 20 cases. Br J Haematol. 1994;87:205.
18. Sullivan PS, Jackson CW, McDonald TP. Castration decreases thrombocytopoiesis and testosterone restores platelet production in castrated BALB/c mice: evidence that testosterone acts on a bipotential hematopoietic precursor cell. J Lab Clin Med. 1995;125:326.
19. Westley B, Rochefort H. A secreted glycoprotein induced by estrogen in human breast cancer cell line. Cell. 1980;20:253.
20. Faraday N, Goldschmidt-Clermont P, Dise K, Bray PF. Quantitation of soluble fibrinogen binding to platelets by fluorescence-activated flow cytometry. J Lab Clin Med. 1994;123:728.
21. Green S, Walter P, Kumar V, et al. Human oestrogen receptor cDNA: sequence, expression and homologylo v-erb-A. Nature. 1986;320:134.
22. Mosselman S, Polman J, Dijkema R. ER β: identification and characterization of a novel human estrogen receptor. FEBS Lett. 1996;392:49.
23. Misrahi M, Alger M, d'Auriol L, et al. Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA. Biochem Biophys Res Commun. 1987;143:740
24. Lubahn DB, Joseph DR, Sar M, et al. The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol. 1988;2: 1265.
25. Nakajima-Iijima S, Hamada H, Reddy P, Kakunaga T. Molecular structure of the human cytoplasmic β actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci U S A. 1985;82:6133.
26. A2. Tissue Antigens. 1995;46: 374.
27. Edelstein RA, Carr MC, Caesar R, Young M, Atala A, Freeman MR. Detection of human androgen receptor mRNA expression abnormalities by competitive PCR. DNA Cell Biol. 1994;13:265.
28. Kitazawa T, Hamada E, Kitazawa K, Gaznabi AK. Non-genomic mechanism of 17 β-oestradiol-induced inhibition of contraction in mammalian vascular smooth muscle. J Physiol (Lond). 1997;499: 497.
29. Picotto G, Massheimer V, Boland R. Acute stimulation of intestinal cell calcium influx induced by 17 β-estradiol via the cAMP messenger system. Mol Cell Endocrinol. 1996;119:129.
30. de Boer W, Bolt J, Kuiper GG, Brinkmann AO, Mulder E. Analysis of steroid- and DNA-binding domains of the calf uterine androgen receptor by limited proteolysis. J Steroid Biochem. 1987;28:9.
31. Kuil CW, Berrevoets CA, Mulder E. Ligand-induced conformational alterations of the androgen receptor analyzed by limited trypsinization: studies on the mechanism of antiandrogen action. J Biol Chem. 1995;170:27,569.
32. Prins GS, Birch L, Greene GL. Androgen receptor localization in different cell types of the adult rat prostate. Endocrinology. 1991;129:3187.
33. Cardone A, Angelini F, Varriale B. Autoregulation of estrogen and androgen receptor mRNAs and downregulation of androgen receptor mRNA by estrogen in primary cultures of lizard testis cells. Gen Comp Endocrinol. 1998;110:227.
34. Prins GS, Woodham C. Autologous regulation of androgen receptor messenger ribonucleic acid in the separate lobes of the rat prostate gland. Biol Reprod. 1995;53:609.
35. Spector DL. Nuclear organization of pre-mRNA processing. Curr Opin Cell Biol. 1993;5:442.
36. Lamond AI, Carmo-Fonseca M. Localisation of splicing snRNPs in mammalian cells. Mol Biol Rep. 1993;18:127.
37. Chung KW. Effects of alcohol feeding on androgen receptors in the rat pituitary gland. Life Sci. 1987;41:2077.
38. Greene GL, Nolan C, Engler JP, Jensen EV. Monoclonal antibodies to human estrogen receptor. Proc Natl Acad Sci U S A. 1980;77:5115.
39. Enmark E, Pelto-Huikko M, Grandien K, et al. Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab. 1997;82:4258.
40. Hanstein B, Liu H, Yancisin MC, Brown M. Functional analysis of a novel estrogen receptor-β isoform. Mol Endocrinol. 1999;13:129.
41. Wilson CM, McPhaul MJ. A and B forms of the androgen receptor are expressed in a variety of human tissues. Mol Cell Endocrinol. 1996; 120:51.
42. Lu B, Leygue E, Dotzlaw H, Murphy LJ, Murphy LC, Watson PH. Estrogen receptor-beta mRNA variants in human and murine tissues. Mol Cell Endocrinol. 1998;16:138:199.
43. Carson-Jurica MA, Schrader WT, O'Malley BW. Steroid receptor family: structure and functions. Endocr Rev. 1990;11:201.
44. Beato M, Chavez S, Truss M. Transcriptional regulation by steroid hormones. Steroids. 1996; 61:240.
45. Sanchez-Medal L, Gomez-Leal A, Duarte L, Guadalupe Rico M. Anabolic androgenic steroids in the treatment of acquired aplastic anemia. Blood. 1969;34:283.
46. Rosse WF. Paroxysmal nocturnal hemoglobinuria: present status and future prospects. West J Med. 1980;132:219.
47. Claustres M, Sultan C. Androgen and erythropoiesis: evidence for an androgen receptor in erythroblasts from human bone marrow cultures. Horm Res. 1988;29:17.
48. Cario-Toumaniantz C, Loirand G, Ferrier L, Pacaud P. Non-genomic inhibition of human P2X7 purinoceptor by 17β-oestradiol. J Physiol (Lond). 1998;508:659.
49. Doolan CM, Harvey BJ. Modulation of cytosolic protein kinase C and calcium ion activity by steroid hormones in rat distal colon. J Biol Chem. 1996;271:8763.
50. Pilo R, Aharony D, Raz A. Testosterone potentiation of ionophore and ADP induced platelet aggregation: relationship to arachidonic acid metabolism. Thromb Haemost. 1981;46:538.
51. Williams JK, Adams MR, Herrington DM, Clarkson TB. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol. 1992;20:452.
52. Gu Q, Korach KS, Moss RL. Rapid action of 17β-estradiol on kainate-induced currents in hippocampal neurons lacking intracellular estrogen receptors. Endocrinology. 1999;140:660.
53. Mooradian AD, Morley JE, Korenman SG. Biological actions of androgens. Endocr Rev. 1987;8:1.
54. Varriale B, Serino I. The androgen receptor mRNA is up-regulated by testosterone in both the Harderian gland and thumb pad of the frog, Rana esculents. J Steroid Biochem Mol Biol. 1994;51: 259.
55. Mizokami A, Saiga H, Matsui T, Mita T, Sugita A. Regulation of androgen receptor by androgen and epidermal growth factor in a human prostatic cancer cell line, LNCaP. Endocrinol Jpn. 1992;39: 235.
56. Hackenberg R, HawighorstT, Filmer A, et al. Regulation of androgen receptor mRNA and protein level by steroid hormones in human mammary cancer cells. J Steroid Biochem Mol Biol. 1992;43:599.
57. Yeap BB, Krueger RG, Leedman PJ. Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells. Endocrinology. 1999;140: 3282.